Ligand profile
ZINC238808944
Virtual-screening candidate from ZINC.
Bound to: KP13_13105 — Thioredoxin-1
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC238808944- UniProt (similar protein)
P0AA25- Tanimoto
- 0.675
- Target protein
- KP13_13105
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 121.5
- −1 ≤ LogP ≤ 5 -0.37
- MW ≤ 500 Da 335.4
- LogP ≤ 5 -0.37
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 13
- TPSA ≤ 140 Ų 121.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCCC(=O)N(C)C[C@H](O)[C@H](O)[C@H](O)[C@@H](O)COCCCCCCCCC(=O)N(C)C[C@H](O)[C@H](O)[C@H](O)[C@@H](O)CO
InChI=1S/C16H33NO6/c1-3-4-5-6-7-8-9-14(21)17(2)10-12(19)15(22)16(23)13(20)11-18/h12-13,15-16,18-20,22-23H,3-11H2,1-2H3/t12-,13-,15-,16+/m0/s1InChI=1S/C16H33NO6/c1-3-4-5-6-7-8-9-14(21)17(2)10-12(19)15(22)16(23)13(20)11-18/h12-13,15-16,18-20,22-23H,3-11H2,1-2H3/t12-,13-,15-,16+/m0/s1
GCRLIVCNZWDCDE-DARAHFNDSA-NGCRLIVCNZWDCDE-DARAHFNDSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- 2CV
- Homolog
- P0AA25
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC238808944 →
- ZINC ZINC20 ZINC238808944 →
- UniProt UniProt P0AA25 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC238808944”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_13105.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).